Latest Hypnotics Stories
REDWOOD CITY, Calif., Oct. 22 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical trial of ARX-03, a proprietary sublingual dosage form combining an opioid, sufentanil, with a benzodiazepine, triazolam.
Researchers say antiepilectic drug treatments administered when the brain is developing appear to trigger schizophrenia-like behavior in animal models.
WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug.
The U.S. Food and Drug Administration announced Wednesday it will require a boxed warning for the injectable form of the drug promethazine. FDA officials said the warning will highlight the risk of serious tissue injury when the drug is administered incorrectly.
SOMERSET, N.J., Sept. 8 /PRNewswire/ -- Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States.
RICHMOND, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., Aug.
A number of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration (FDA), according to a recent national survey. â€œOff-label useâ€ refers to prescribing a drug for a purpose outside the scope of a drug's approved label.
RICHMOND, Calif., Aug. 26 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc.
Certain types of medications given to the elderly could add to their risk of falling, according to a new study.